Search stocks

Find any stock by ticker or company name

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

RMD - ResMed Inc. So'nggi Yangiliklar | Finranks

Home

/

RMD

R

ResMed Inc. (RMD)

NYQ – Real vaqt narxi. Valyuta: USD

226.01

+1.17 (0.52%)

Yopilishda: Aug 12, 2026, 3:59 PM EDT

197.78

-28.22 (-12.49%)

Bozordan keyin: Aug 12, 2026, 5:27 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Top 50 High-Quality Dividend Growth Stocks For August 2026

Top 50 High-Quality Dividend Growth Stocks For August 2026

I track a curated universe of 50 high-quality dividend growth stocks to identify timely, attractive entry points for long-term total return. The universe delivered a 10.44% YTD return through July, closely matching SPY but trailing SCHD, with several individual stocks significantly outperforming. Currently, 40 stocks in the universe offer a forward return estimate of at least 10%, with 25 appearing potentially undervalued based on free cash flow analysis.

ResMed Q4 Earnings Call Highlights

ResMed Q4 Earnings Call Highlights

ResMed NYSE: RMD reported fourth-quarter fiscal 2026 revenue growth of 9% on a reported basis, or 8% in constant currency, as demand for sleep devices and masks increased. Non-GAAP earnings per share rose 16% to $2.95, while the company expanded gross margin despite continued inflation in electronic components and freight.

RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y

RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y

Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.

ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat

ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat

Shares of ResMed dropped about 6% in morning trade on Friday after the medtech company forecast fiscal 2027 revenue below Wall Street expectations, impacted by suspended ventilator sales and cost pressures.

ResMed Inc. (RMD) Q4 2026 Earnings Call Transcript

ResMed Inc. (RMD) Q4 2026 Earnings Call Transcript

ResMed Inc. (RMD) Q4 2026 Earnings Call Transcript

ResMed (RMD) Q4 Earnings and Revenues Top Estimates

ResMed (RMD) Q4 Earnings and Revenues Top Estimates

ResMed (RMD) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.9 per share. This compares to earnings of $2.55 per share a year ago.

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

Q4 revenue increased by 9% to a record $1.5 billion; up 8% on a constant currency basis Q4 GAAP diluted earnings per share up 2% to $2.64; non-GAAP diluted earnings per share up 16% to $2.95 Returned $1.0 billion to shareholders through share repurchases and dividends during FY2026, an increase of more than 70% Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2026.

Videolar

No Data

There is no data to display

Press-relizlar

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

Q4 revenue increased by 9% to a record $1.5 billion; up 8% on a constant currency basis Q4 GAAP diluted earnings per share up 2% to $2.64; non-GAAP diluted earnings per share up 16% to $2.95 Returned $1.0 billion to shareholders through share repurchases and dividends during FY2026, an increase of more than 70% Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2026.